Alx Oncology Holdings (ALXO) Non-Current Debt (2019 - 2026)
Alx Oncology Holdings' Non-Current Debt was $9.71 million in Q2 2026, up 38.7% from $7 million a year earlier and up 194.5% from the prior quarter.
Powered by 
Analysis
Alx Oncology Holdings (ALXO) Non-Current Debt (2019 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Debt at Alx Oncology Holdings came in at $4.53 million, down 52.1% from FY2024.
- Non-Current Debt shows a three-year compound annual growth rate of -21.6% (FY2022 to FY2025).
- In earlier years, Non-Current Debt was $9.47 million in FY2024 (-1.8%), $9.64 million in FY2023 (+2.7%) and $9.39 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Non-Current Debt since Q3 2024.
- Compared with a year earlier, Non-Current Debt was higher in two of the last eight quarters, with an average decline of 19.7%.
- The best year-over-year quarter for Non-Current Debt over five years was Q2 2026 (growth of 38.7%); the worst was Q1 2026 (a decline of 60.0%).
- Per Business Quant data, ALXO's Non-Current Debt in the three quarters before Q2 2026 was $3.3 million (Q1 2026), $4.53 million (Q4 2025) and $5.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Alx Oncology Holdings | 192.12 Mn | 192.12 Mn | - | 9.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.71 Mn |
| Mar 31, 2026 | 3.30 Mn |
| Dec 31, 2025 | 4.53 Mn |
| Sep 30, 2025 | 5.76 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 8.23 Mn |
| Dec 31, 2024 | 9.47 Mn |
| Sep 30, 2024 | 9.84 Mn |
| Jun 30, 2024 | 9.77 Mn |
| Mar 31, 2024 | 9.70 Mn |
| Dec 31, 2023 | 9.64 Mn |
| Sep 30, 2023 | 9.58 Mn |
| Jun 30, 2023 | 9.51 Mn |
| Mar 31, 2023 | 9.45 Mn |
| Dec 31, 2022 | 9.39 Mn |
| Sep 30, 2020 | 3.19 Mn |
| Jun 30, 2020 | 3.93 Mn |
| Dec 31, 2019 | 5.42 Mn |
API Access
Alx Oncology Holdings Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=ALXO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "ALXO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=ALXO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();